DK1019374T3 - Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde - Google Patents

Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde

Info

Publication number
DK1019374T3
DK1019374T3 DK97924337T DK97924337T DK1019374T3 DK 1019374 T3 DK1019374 T3 DK 1019374T3 DK 97924337 T DK97924337 T DK 97924337T DK 97924337 T DK97924337 T DK 97924337T DK 1019374 T3 DK1019374 T3 DK 1019374T3
Authority
DK
Denmark
Prior art keywords
polymorphic
manufacturing process
donepezil hydrochloride
donepezil
hydrochloride
Prior art date
Application number
DK97924337T
Other languages
Danish (da)
English (en)
Inventor
Akio Imai
Hideaki Watanabe
Takashi Kajima
Yasushi Ishihama
Akiyo Ohtsuka
Tomohide Tanaka
Yukio Narabu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1996/003881 external-priority patent/WO1997046526A1/en
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DK1019374T3 publication Critical patent/DK1019374T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97924337T 1996-06-07 1997-06-06 Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde DK1019374T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14629396 1996-06-07
PCT/JP1996/003881 WO1997046526A1 (en) 1996-06-07 1996-12-27 Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
US08/774,802 US6140321A (en) 1996-06-07 1996-12-30 Polymorphs of donepezil hydrochloride and process for production
PCT/JP1997/001932 WO1997046527A1 (en) 1996-06-07 1997-06-06 Polymorphs of donepezil hydrochloride and process for production

Publications (1)

Publication Number Publication Date
DK1019374T3 true DK1019374T3 (da) 2003-04-07

Family

ID=27307991

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97924337T DK1019374T3 (da) 1996-06-07 1997-06-06 Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde

Country Status (12)

Country Link
EP (2) EP1019374B1 (ru)
AU (1) AU731282B2 (ru)
CA (1) CA2252806C (ru)
DK (1) DK1019374T3 (ru)
ES (1) ES2188946T3 (ru)
HK (1) HK1020952A1 (ru)
NO (1) NO321267B1 (ru)
NZ (1) NZ333197A (ru)
RU (1) RU2190603C2 (ru)
SI (1) SI9720038B (ru)
SK (1) SK285312B6 (ru)
WO (1) WO1997046527A1 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2282654C (en) 1997-03-03 2009-02-03 Eisai Co., Ltd. Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
ATE260896T1 (de) 1997-12-05 2004-03-15 Eisai Co Ltd Donepezil polykristalle und verfharen zu ihrer herstellung
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
IL138914A0 (en) * 1998-06-16 2001-11-25 Lilly Co Eli Methods for increasing levels of acetylcholine
WO1999065489A1 (en) * 1998-06-16 1999-12-23 Eli Lilly And Company Methods for increasing levels of acetylcholine
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
DK1311272T3 (da) 2000-03-03 2007-02-26 Eisai R&D Man Co Ltd Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer
SI21223A (sl) * 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
IL150509A (en) 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
WO2004041281A1 (en) * 2002-11-01 2004-05-21 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
WO2006011154A1 (en) * 2004-07-28 2006-02-02 Usv Limited A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof
US7186842B2 (en) 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
US20050288330A1 (en) * 2004-06-29 2005-12-29 Avinash Naidu Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
US7560560B2 (en) * 2003-04-16 2009-07-14 Hetero Drugs Limited Crystalline forms of donepezil hydrochloride
EP1773339A4 (en) * 2004-07-30 2009-07-29 Reddys Lab Ltd Dr CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE
ATE415148T1 (de) 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
WO2006090263A1 (en) * 2005-02-28 2006-08-31 Ranbaxy Laboratories Limited Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions
WO2006097341A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Process for making crystalline donepezil hydrochloride monohydrate
WO2006111983A2 (en) * 2005-04-21 2006-10-26 Jubilant Organosys Limited NOVEL POLYMORPHIC FORM OF (l-BENZYL-4-[(5,6-DIMETHOXY-l- INDANONE)-2-YL]METHYL PIPERIDINE HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
GB0515803D0 (en) * 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
HU227474B1 (en) * 2005-12-20 2011-07-28 Richter Gedeon Nyrt Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
US20100204470A1 (en) 2006-06-27 2010-08-12 Sandoz Ag method for salt preparation
US8247563B2 (en) * 2006-12-11 2012-08-21 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
ES2415166T3 (es) * 2007-09-28 2013-07-24 Tianjin Hemay Bio-Tech Co., Ltd. Polímorfos de sales de Donepezilo, métodos de preparación y usos de los mismos
WO2010071216A1 (en) * 2008-12-17 2010-06-24 Eisai R&D Management Co., Ltd. Polymorphic crystal of donepezil and process for producing the same
DE102010010998A1 (de) 2010-03-10 2011-09-15 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (en) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil
CN110393440B (zh) * 2019-06-28 2021-08-13 顾美红 一种即热式烧水机

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi

Also Published As

Publication number Publication date
NZ333197A (en) 2001-03-30
EP1019374A1 (en) 2000-07-19
CA2252806A1 (en) 1997-12-11
CA2252806C (en) 2005-11-22
HK1020952A1 (en) 2000-05-26
NO985721D0 (no) 1998-12-07
RU2190603C2 (ru) 2002-10-10
AU2979297A (en) 1998-01-05
EP1019374B1 (en) 2003-01-02
AU731282B2 (en) 2001-03-29
WO1997046527A1 (en) 1997-12-11
SI9720038A (sl) 1999-06-30
SI9720038B (sl) 2010-06-30
NO321267B1 (no) 2006-04-10
SK167698A3 (en) 1999-06-11
SK285312B6 (sk) 2006-10-05
ES2188946T3 (es) 2003-07-01
EP1211243B1 (en) 2009-10-14
NO985721L (no) 1999-01-28
EP1211243A1 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
DK1019374T3 (da) Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde
NO970762L (no) Brönnstrengskjötlokalisator og fremgangsmåte derved
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
NO990122D0 (no) Nedihullverkt°y og fremgangsmÕte
DE69841064D1 (de) Widerstand und Herstellungsverfahren dafür
NO984373L (no) FremgangsmÕte og anordning hvor kveil-i-kveil-r°r benyttes
NO20022086L (no) Antidiabetisk formulering og fremgangsmåte
DK0850948T3 (da) Propiophenonderivater og fremgangsmåde til fremstilling deraf
IS8717A (is) Ísókínólín og framleiðsla þeirra
DE69808499D1 (de) Widerstand und herstellungsverfahren
NO20002584L (no) Brønnreferanseapparat og fremgangsmÕte
KR960012601A (ko) 원-직선편파변환기 및 그의 제조방법
DE19781945T1 (de) Biegeverfahren und Biegevorrichtung
DE69904731T2 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
EE200000222A (et) Amiinimise protsess
DE69522846T2 (de) Verbesserte Speicheranordnung und Herstellungsverfahren
NO984861D0 (no) Piperidiner og pyrrolidiner
KR960009144A (ko) 리드프레임과 그 제조방법
DE69713155D1 (de) Halbleiteranordnung und herstellungsverfahren
DK0891938T3 (da) Maskine og fremgangsmåde til stabling
DE69805736D1 (de) Umformverfahren und Umformwerkzeug
NO985806L (no) Kitinasematerialer og fremgangsmÕter
NO942643D0 (no) Demodulator og fremgangsmåte derved
NO970489D0 (no) Brönnperforeringsisolasjonsapparat og metode
DK1078458T3 (da) Timingindretning og timingfremgangsmåde